title: Exfoliative erythroderma after tumor necrosis factor-α inhibitor therapy.
authors.affiliation: Department of Dermatology, Mayo Clinic, Rochester, MN, USA. elazhary.rokea2@mayo.edu.
authors.forename: Rokea A
authors.initials: RA
authors.lastname: el-Azhary
authors.affiliation: Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Julia S
authors.initials: JS
authors.lastname: Lehman
mesh_terms: D000068879:Adalimumab / Q000009:adverse effects*; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab